These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17217200)

  • 1. [Hyper-IGE reactions in uveitis and their immunomodulation with cytokine-containing agents].
    Teplinskaia LE; Filichkina NS
    Vestn Oftalmol; 2006; 122(6):33-5. PubMed ID: 17217200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficiency of treatment of uveitis with the drug superlymph].
    Teplinskaia LE; Filichkina NS; Matevosova KS
    Vestn Oftalmol; 2005; 121(4):22-6. PubMed ID: 16223038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and differentiated treatment of secondary immunodeficiencies].
    Kolesnikov AP; Khabarov AS; Kozlov VA
    Ter Arkh; 2001; 73(4):55-9. PubMed ID: 11494450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C; Buhl R
    Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic peculiarities of uveitis concurrent with systemic pathologies].
    Drozdova EA; Tarasova LN; Teplova SN; Alekhina TV
    Vestn Oftalmol; 2004; 120(4):24-6. PubMed ID: 15384843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New biologic drugs: anti-interleukin therapy.
    Tappeiner C; Möller B; Hennig M; Heiligenhaus A
    Dev Ophthalmol; 2012; 51():79-89. PubMed ID: 22517206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic dermatitis: an update and review of the literature.
    Lipozencić J; Wolf R
    Dermatol Clin; 2007 Oct; 25(4):605-12, x. PubMed ID: 17903619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of impaired immune response regulatory processes in the pathogenesis of uveitis associated with rheumatic diseases].
    Drozdova EA; Teplova SN
    Vestn Oftalmol; 2008; 124(3):23-6. PubMed ID: 18589650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological response modifiers in the treatment of noninfectious uveitis.
    Kopplin LJ; Shifera AS; Suhler EB; Lin P
    Int Ophthalmol Clin; 2015; 55(2):19-36. PubMed ID: 25730617
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenic uveitis. Wherein it is demonstrated that the cure may sometimes be worse than the disease.
    Silverstein AM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):496-517. PubMed ID: 4619854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selected immunologic parameters in uveitis].
    Wieczorek E; Hańczyc P; Prastowska E
    Klin Oczna; 1989 Jan; 91(1):14-6. PubMed ID: 2811187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in experimental and clinical uveitis.
    Singh VK; Rai G; Agarwal SS
    Indian J Ophthalmol; 2001 Jun; 49(2):81-90. PubMed ID: 15884511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary immune deficiencies with aberrant IgE production.
    Ozcan E; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2008 Dec; 122(6):1054-62; quiz 1063-4. PubMed ID: 19084106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis, immunopathogenesis, clinical picture and treatment of uveitis in nephropathies].
    Teplinskaia LE; Kaliberdina AF
    Vestn Oftalmol; 2000; 116(5):39-42. PubMed ID: 11221380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological mechanisms of the tissue lesions in endogenous uveitis].
    Todea V
    Oftalmologia; 1994; 38(3):201-4. PubMed ID: 8060956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic disorders in endogenous uveitis and the possible means of their correction by drugs].
    Vanichkin AA; Shpak NI
    Oftalmol Zh; 1982; 37(1):10-3. PubMed ID: 6979018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating immune complexes in children with uveitis].
    Hańczyc P; Wieczorek E; Prastowska E; Prusek W
    Klin Oczna; 1989 Jan; 91(1):12-4. PubMed ID: 2811186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and immunological criteria for predicting the course of uveitis].
    Chentsova OB
    Vestn Oftalmol; 1999; 115(2):23-5. PubMed ID: 10377869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.